Celldex Therapeutics, Inc. (CLDX)

Healthcare · Biotechnology · NASDAQ

Celldex Therapeutics, Inc. (CLDX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.63B and a free-cash-flow yield of -9.6%. Over the most recent reported fiscal year, revenue declined 78.0%.

Market cap	$2.63B
Trailing P/E	—
FCF yield	-9.6%
Revenue growth (YoY)	-78.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live CLDX data on Nama Insights →